The objective of the MAGBBRIS Project is to enhance ischemic tissue remodelling by encapsulating EPCs-secretome into biocompatible nanocapsules labelled with magnetic nanoparticles and fluorescent tags, allowing magnetic guidance and retention, simultaneous in vivo imaging and controlled release.
MAGBBRIS is a highly multidisciplinary consortium integrated by 6 partners from 5 European countries, involved in materials-science, biomedical and clinical research and industrial partnership.
4th of February 2020
31st of March 2020
MAGBBRIS Annual Meeting
5-6h of May 2020